Skip to main content
. 2021 Feb 17;25:70. doi: 10.1186/s13054-021-03504-w

Table 2.

Treatments and (ICU) LOS by 2-week cohorts

Overall (n = 620) First period (n = 35) Second period (n = 168) Third period (n = 164) Fourth period (n = 125) Fifth period (n = 94) Sixth period (n = 34) P value
Date range Mar 01–May 15 Mar 01–Mar 14 Mar 15–Mar 28 Mar 29–April 11 April 12–April 25 April 26–May 09 May 10–May 15
Hydroxychloroquine, n (%) 321 (51.8) 15 (42.9) 127 (75.6) 99 (60.4) 59 (47.2) 17 (18.1) 4 (11.8) < 0.001
Remdesivir, n (%) 109 (17.6) 4 (11.4) 31 (18.5) 33 (20.1) 11 (8.8) 24 (25.5) 6 (17.6) 0.029
Tocilizumab, n (%) 88 (14.2) 1 (2.9) 22 (13.1) 27 (16.5) 23 (18.4) 11 (11.7) 4 (11.8) 0.220
Dexamethasone, n (%) 28 (4.5) 0 (0.0) 10 (6.0) 6 (3.7) 7 (5.6) 4 (4.3) 1 (2.9) 0.655
Room air, n (%) 507 (81.8) 31 (88.6) 145 (86.3) 133 (81.1) 95 (76.0) 75 (79.8) 28 (82.4) 0.260
Nasal cannula, n (%) 529 (85.3) 32 (91.4) 150 (89.3) 141 (86.0) 103 (82.4) 75 (79.8) 28 (82.4) 0.252
Mask, n (%) 411 (66.3) 25 (71.4) 119 (70.8) 105 (64.0) 79 (63.2) 60 (63.8) 23 (67.6) 0.676
Continuous positive airway pressure (CPAP), n (%) 78 (12.6) 6 (17.1) 22 (13.1) 23 (14.0) 13 (10.4) 12 (12.8) 2 (5.9) 0.709
Bi-level positive airway pressure (BIPAP), n (%) 87 (14.0) 4 (11.4) 24 (14.3) 16 (9.8) 20 (16.0) 17 (18.1) 6 (17.6) 0.448
High-flow nasal cannula, n (%) 296 (47.7) 10 (28.6) 56 (33.3) 86 (52.4) 76 (60.8) 50 (53.2) 18 (52.9) < 0.001
Invasive mechanical ventilation, n (%) 371 (59.8) 23 (65.7) 131 (78.0) 98 (59.8) 65 (52.0) 40 (42.6) 14 (41.2) < 0.001
Prone ventilation, n (%) 356 (57.4) 16 (45.7) 97 (57.7) 97 (59.1) 87 (69.6) 47 (50.0) 12 (35.3) 0.002
Duration of invasive mechanical ventilation (days), median (IQR) 9.1 (4.7–14.4) 8.6 (3.5–17.0) 9.9 (7.0–15.4) 7.4 (4.1–12.1) 8.9 (3.9–15.9) 8.7 (4.0–15.7) 3.9 (2.5–9.6) 0.018
ICU length of stay (LOS) (days), median (IQR) 6.2 (2.7–12.5) 4.8 (3.4–13.7) 9.1 (3.5–13.6) 6.0 (2.5–11.4) 6.2 (2.3–14.1) 5.0 (2.6–9.1) 4.0 (1.5–7.4) 0.004
Hospital LOS (days), median (IQR) 12.7 (7.5–21.8) 10.7 (7.1–28.4) 14.1 (8.1–23.0) 13.6 (8.3–22.1) 13.4 (7.2–21.6) 10.0 (5.9–17.02) 8.7 (5.5–16.1) 0.009